Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more
Masimo Corporation (MASI) - Net Assets
Latest net assets as of December 2025: $721.20 Million USD
Based on the latest financial reports, Masimo Corporation (MASI) has net assets worth $721.20 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.70 Billion) and total liabilities ($977.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $721.20 Million |
| % of Total Assets | 42.45% |
| Annual Growth Rate | 15.51% |
| 5-Year Change | -53.48% |
| 10-Year Change | 28.73% |
| Growth Volatility | 144.03 |
Masimo Corporation - Net Assets Trend (1998–2025)
This chart illustrates how Masimo Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Masimo Corporation (1998–2025)
The table below shows the annual net assets of Masimo Corporation from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $721.20 Million | -31.44% |
| 2024-12-31 | $1.05 Billion | -22.93% |
| 2023-12-31 | $1.36 Billion | +1.93% |
| 2022-12-31 | $1.34 Billion | -13.63% |
| 2021-12-31 | $1.55 Billion | +10.13% |
| 2020-12-31 | $1.41 Billion | +20.53% |
| 2019-12-31 | $1.17 Billion | +20.52% |
| 2018-12-31 | $969.07 Million | +33.84% |
| 2017-12-31 | $724.02 Million | +29.24% |
| 2016-12-31 | $560.24 Million | +103.20% |
| 2015-12-31 | $275.71 Million | -10.41% |
| 2014-12-31 | $307.74 Million | -5.72% |
| 2013-12-31 | $326.40 Million | +18.40% |
| 2012-12-31 | $275.67 Million | -1.43% |
| 2011-12-31 | $279.67 Million | +21.57% |
| 2010-12-31 | $230.04 Million | -20.59% |
| 2009-12-31 | $289.69 Million | +31.98% |
| 2008-12-31 | $219.50 Million | +46.27% |
| 2007-12-31 | $150.07 Million | +163.45% |
| 2006-12-31 | $56.96 Million | +156.35% |
| 2005-12-31 | $-101.08 Million | +12.40% |
| 2003-12-31 | $-115.39 Million | -15.17% |
| 2002-12-31 | $-100.19 Million | -624.57% |
| 1999-12-31 | $19.10 Million | +29.93% |
| 1998-12-31 | $14.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Masimo Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 137130000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.34 Billion | 185.72% |
| Common Stock | $100.00K | 0.01% |
| Other Comprehensive Income | $-12.50 Million | -1.73% |
| Total Equity | $721.20 Million | 100.00% |
Masimo Corporation Competitors by Market Cap
The table below lists competitors of Masimo Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Molybdenum Co. Ltd
PINK:CMCLF
|
$8.12 Billion |
|
Power Assets Holdings Limited
PINK:HGKGF
|
$8.13 Billion |
|
China Development Financial Holding Corp
TW:2883
|
$8.13 Billion |
|
Littelfuse Inc
NASDAQ:LFUS
|
$8.13 Billion |
|
Acuity Brands Inc
NYSE:AYI
|
$8.11 Billion |
|
Swiss Prime Site AG
PINK:SWPRF
|
$8.10 Billion |
|
Auckland International Airport Limited
PINK:ACKDF
|
$8.10 Billion |
|
Alstom S.A.
PA:ALO
|
$8.09 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Masimo Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,051,900,000 to 721,200,000, a change of -330,700,000 (-31.4%).
- Net loss of 151,500,000 reduced equity.
- Share repurchases of 363,700,000 reduced equity.
- New share issuances of 71,400,000 increased equity.
- Other comprehensive income increased equity by 95,700,000.
- Other factors increased equity by 17,400,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-151.50 Million | -21.01% |
| Share Repurchases | $363.70 Million | -50.43% |
| Share Issuances | $71.40 Million | +9.9% |
| Other Comprehensive Income | $95.70 Million | +13.27% |
| Other Changes | $17.40 Million | +2.41% |
| Total Change | $- | -31.44% |
Book Value vs Market Value Analysis
This analysis compares Masimo Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.22x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 632.06x to 13.22x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $0.28 | $175.97 | x |
| 1999-12-31 | $0.36 | $175.97 | x |
| 2002-12-31 | $-3.04 | $175.97 | x |
| 2003-12-31 | $-3.50 | $175.97 | x |
| 2005-12-31 | $-7.71 | $175.97 | x |
| 2006-12-31 | $2.80 | $175.97 | x |
| 2007-12-31 | $2.51 | $175.97 | x |
| 2008-12-31 | $3.64 | $175.97 | x |
| 2009-12-31 | $4.80 | $175.97 | x |
| 2010-12-31 | $3.76 | $175.97 | x |
| 2011-12-31 | $4.55 | $175.97 | x |
| 2012-12-31 | $4.68 | $175.97 | x |
| 2013-12-31 | $5.68 | $175.97 | x |
| 2014-12-31 | $5.51 | $175.97 | x |
| 2015-12-31 | $5.13 | $175.97 | x |
| 2016-12-31 | $10.53 | $175.97 | x |
| 2017-12-31 | $12.96 | $175.97 | x |
| 2018-12-31 | $17.29 | $175.97 | x |
| 2019-12-31 | $20.45 | $175.97 | x |
| 2020-12-31 | $24.25 | $175.97 | x |
| 2021-12-31 | $26.87 | $175.97 | x |
| 2022-12-31 | $24.26 | $175.97 | x |
| 2023-12-31 | $25.23 | $175.97 | x |
| 2024-12-31 | $19.74 | $175.97 | x |
| 2025-12-31 | $13.31 | $175.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Masimo Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -21.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.92%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 2.36x
- Recent ROE (-21.01%) is below the historical average (20.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -56.46% | -488.24% | 0.09x | 1.22x | $-9.77 Million |
| 1999 | -70.68% | -201.49% | 0.28x | 1.27x | $-15.41 Million |
| 2002 | 0.00% | -0.47% | 1.19x | 0.00x | $9.84 Million |
| 2003 | 0.00% | -14.75% | 1.16x | 0.00x | $4.65 Million |
| 2005 | 0.00% | 30.94% | 1.07x | 0.00x | $43.49 Million |
| 2006 | 319.21% | 81.05% | 1.41x | 2.79x | $176.13 Million |
| 2007 | 28.16% | 16.49% | 1.09x | 1.57x | $27.25 Million |
| 2008 | 14.55% | 10.40% | 1.05x | 1.34x | $9.99 Million |
| 2009 | 18.44% | 15.25% | 0.98x | 1.23x | $24.36 Million |
| 2010 | 32.30% | 18.14% | 1.31x | 1.36x | $50.77 Million |
| 2011 | 23.01% | 14.51% | 1.20x | 1.32x | $36.02 Million |
| 2012 | 22.80% | 12.63% | 1.32x | 1.37x | $34.96 Million |
| 2013 | 17.88% | 10.67% | 1.25x | 1.34x | $25.73 Million |
| 2014 | 23.70% | 12.36% | 1.04x | 1.85x | $41.92 Million |
| 2015 | 30.25% | 13.22% | 1.05x | 2.18x | $55.76 Million |
| 2016 | 53.67% | 42.18% | 0.87x | 1.46x | $244.64 Million |
| 2017 | 18.18% | 16.66% | 0.87x | 1.25x | $59.21 Million |
| 2018 | 19.97% | 22.55% | 0.74x | 1.19x | $96.64 Million |
| 2019 | 16.80% | 20.92% | 0.67x | 1.20x | $79.43 Million |
| 2020 | 17.07% | 21.01% | 0.67x | 1.22x | $99.54 Million |
| 2021 | 14.81% | 18.53% | 0.66x | 1.22x | $74.58 Million |
| 2022 | 10.72% | 7.05% | 0.63x | 2.40x | $9.61 Million |
| 2023 | 5.97% | 3.98% | 0.67x | 2.23x | $-54.98 Million |
| 2024 | -28.99% | -14.56% | 0.80x | 2.50x | $-410.09 Million |
| 2025 | -21.01% | -9.92% | 0.90x | 2.36x | $-223.62 Million |
Industry Comparison
This section compares Masimo Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Masimo Corporation (MASI) | $721.20 Million | -56.46% | 1.36x | $8.11 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |